Navigation Links
Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Date:9/18/2007

KENILWORTH, N.J., Sept. 18 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) will provide a live audio webcast of a presentation by Alex Kelly, vice president, Investor Relations, speaking about the company at the Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference in London on Sept. 19, 2007, at approximately 9 a.m. (London) (approximately 4 a.m. EDT).

Kelly will be speaking on the company's financial performance and the planned acquisition of Organon BioSciences N.V. (OBS). He may also reiterate the company's outlook, as previously stated in the company's second quarter 10-Q, on the following:

-- Sales of VYTORIN and ZETIA are expected to grow in 2007. However,

there is growing competition for Schering-Plough's key brands;

-- Gross margin for the full year of 2007 is expected to improve versus

2006, primarily as a result of annual cost savings of approximately

$100 million expected from the company's manufacturing streamlining

actions in 2006 and improved product mix. However, gross margin in the

second half of 2007 is expected to be slightly lower than the first

half due to the seasonality of some respiratory products;

-- As Schering-Plough's pipeline continues to progress, the company

expects that the number of patients in its clinical trials will

continue to increase in the remainder of 2007. R&D expenses, excluding

any upfront payments, are expected to continue to grow faster than

adjusted net sales in 2007. Adjusted net sales is defined as net sales

plus an assumed 50 percent of the global cholesterol joint venture net

sales;

-- The company's full-year 2007 tax rate is expected to be in the mid-

teens on a GAAP basis, but vary between quarters depending on the

product and country mix of earnings; and

-- In advance of the planned acquisition of OBS, the company will incur

integration planning-related costs and potential foreign currency-

related activity associated with the purchase. The transaction is

anticipated to be accretive to the company's earnings per share in the

first full year, excluding purchase-accounting adjustments and

acquisition-related costs. The company expects to achieve annual

synergies of $500 million, however, it is expected that it will take

three years from the closing to reach this level of synergies.

A live audio webcast of the presentation will be available by going to the Investor Relations section of the Schering-Plough corporate Web site, http://www.schering-plough.com, and clicking on the "Presentations/Webcasts" link. A replay of the webcast will be available later that day.

Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its approximately 33,500 people around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Sonic Foundry to Webcast Bridge Arch Floating Down Mississippi
2. New Sonic Foundry search engine finds words, phrases in video presentations
3. Sonic Foundry creates search engine for 7,000 expert video presentations
4. InvestMidWest calls for business presentations
5. BxVideo designs Web hosting service for Sonic Foundry media presentations
6. Distance Education Conference Selects Sonic Foundry to Make Keynotes, Panel Presentations Available On-Demand
7. Ethanol plant builder to expand Merrill facility
8. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
9. The state of global biotech: An Ernst & Young perspective
10. Doyle announces new energy, global warming policies
11. Lucigen Corp. enters global licensing agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... 31, 2016 BioRap Technologies Ltd ... Biomedical Research at the Technion - Israel Institute of Technology, ... with Pfizer Inc. (NYSE: PFE ) that aims ... treatment options for a number of chronic autoimmune diseases. ... by Prof. Nathan Karin and his research team, ...
(Date:5/31/2016)... MB (PRWEB) , ... May 31, 2016 , ... ... develops and markets molecular imaging systems, today announced that their compact PET scanner ... (Magnetic Resonance Imaging) has been selected by the University of Arizona (UA). , ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Weeks after hosting ... in Phoenix, Dr. Michael Fitzmaurice, hand surgeon and founder of the Fitzmaurice Hand Institute, ... The Wrist MRI machine is a state-of-the-art technology and only 1 of about 3 ...
(Date:5/27/2016)... Jersey and READING, ... -- Indegene ( http://www.indegene.com ), ... marketingorientierten Lösungen für die Life-Science-Branche, Pharmaunternehmen und ... bekannter weltweiter Anbieter von innovativen wissenschaftlichen Support-Services ... des Starts von IntraScience heute den Ausbau ...
Breaking Biology Technology:
(Date:3/15/2016)... March 15, 2016 --> ... by Transparency Market Research "Digital Door Lock Systems Market - ... - 2023," the global digital door lock systems market in ... 2014 and is forecast to grow at a CAGR of ... small and medium enterprises (MSMEs) across the world and high ...
(Date:3/14/2016)... , Allemagne, March 14, 2016 ... http://www.apimages.com ) - --> - Renvoi : ... - --> --> ... solutions biométriques, fournit de nouveaux lecteurs d,empreintes digitales ... LF10 de DERMALOG sera utilisé pour produire des ...
(Date:3/10/2016)... , March 10, 2016 ... market research report "Identity and Access Management Market by ... Compliance, and Governance), by Organization Size, by Deployment, by ... published by MarketsandMarkets, The market is estimated to grow ... Billion by 2020, at a Compound Annual Growth Rate ...
Breaking Biology News(10 mins):